The increased SAD values in sAML samples indicate the existence of a small number of bone marrow cells with prominent levels of separase proteolytic activity when compared to levels regularly measured in corresponding cells of MDS patients and healthy controls. The gene discussed is ESPL1; the disease is myelodysplastic syndrome.